Summary
This research demonstrates that ipRGCs express μ-opioid receptors and that opioid application inhibits their firing, suggesting that opioid medications may directly impair the light-sensing cells responsible for circadian entrainment. For healthcare and lighting design, this implies that patients on opioid therapy may have reduced circadian light responsiveness, potentially necessitating adjusted light exposure strategies to maintain circadian health.
Key Findings
- ipRGCs express μ-opioid receptors (MORs)
- Exogenously applied opioids inhibit the firing of ipRGCs, indicating functional opioid modulation of the primary circadian photoreceptor pathway
Categories
The Science of Light: Examines opioid receptor expression on ipRGCs and how opioid signaling modulates intrinsically photosensitive retinal ganglion cell firing, directly relevant to photoreceptor biology.
Patient Recovery: Has implications for patients receiving opioid medications, as opioid modulation of ipRGCs could affect circadian entrainment and light-mediated physiological responses in clinical settings.
Author(s)
AM Cleymaet
Publication Year
2019
Related Publications
The Science of Light
- Phototransduction by retinal ganglion cells that set the circadian clock
- Color appearance models
- The mammalian circadian timing system: organization and coordination of central and peripheral clocks
- Diminished pupillary light reflex at high irradiances in melanopsin-knockout mice
- Melanopsin is required for non-image-forming photic responses in blind mice
Patient Recovery
- Light during darkness and cancer: relationships in circadian photoreception and tumor biology
- An overview of the effects of light on human circadian rhythms: Implications for new light sources and lighting systems design
- Application of different circadian lighting metrics in a health residence
- Melatonin and cortisol in individuals with spinal cord injury
- Sustainable lighting for healthcare facilities: More than just lumens per watt